全文获取类型
收费全文 | 176174篇 |
免费 | 3796篇 |
国内免费 | 1648篇 |
专业分类
耳鼻咽喉 | 1718篇 |
儿科学 | 6116篇 |
妇产科学 | 2868篇 |
基础医学 | 19977篇 |
口腔科学 | 4426篇 |
临床医学 | 11842篇 |
内科学 | 32285篇 |
皮肤病学 | 3059篇 |
神经病学 | 9772篇 |
特种医学 | 3588篇 |
外国民族医学 | 291篇 |
外科学 | 26431篇 |
综合类 | 13191篇 |
一般理论 | 4篇 |
预防医学 | 10254篇 |
眼科学 | 3276篇 |
药学 | 19413篇 |
8篇 | |
中国医学 | 7611篇 |
肿瘤学 | 5488篇 |
出版年
2022年 | 776篇 |
2021年 | 2008篇 |
2020年 | 930篇 |
2019年 | 12502篇 |
2018年 | 12249篇 |
2017年 | 5315篇 |
2016年 | 908篇 |
2015年 | 937篇 |
2014年 | 5920篇 |
2013年 | 6448篇 |
2012年 | 4342篇 |
2011年 | 4018篇 |
2010年 | 5127篇 |
2009年 | 4812篇 |
2008年 | 3525篇 |
2007年 | 3702篇 |
2006年 | 3932篇 |
2005年 | 3858篇 |
2004年 | 3016篇 |
2003年 | 3099篇 |
2002年 | 3020篇 |
2001年 | 3026篇 |
2000年 | 3262篇 |
1999年 | 2942篇 |
1998年 | 3001篇 |
1997年 | 2360篇 |
1996年 | 2211篇 |
1995年 | 2588篇 |
1994年 | 2418篇 |
1993年 | 1882篇 |
1992年 | 1478篇 |
1991年 | 1479篇 |
1990年 | 1229篇 |
1989年 | 971篇 |
1988年 | 1012篇 |
1987年 | 976篇 |
1986年 | 816篇 |
1985年 | 5396篇 |
1984年 | 7271篇 |
1983年 | 5817篇 |
1982年 | 6252篇 |
1981年 | 5703篇 |
1980年 | 4901篇 |
1979年 | 4958篇 |
1978年 | 4061篇 |
1977年 | 3047篇 |
1976年 | 3522篇 |
1975年 | 2732篇 |
1974年 | 2523篇 |
1973年 | 2226篇 |
排序方式: 共有10000条查询结果,搜索用时 78 毫秒
31.
32.
《Vaccine》2022,40(6):934-944
Respiratory Syncytial Virus (RSV) remains a leading cause of severe respiratory disease for which no licensed vaccine is available. We have previously described the derivation of an RSV Fusion protein (F) stabilized in its prefusion conformation (preF) as vaccine immunogen and demonstrated superior immunogenicity in naive mice of preF versus wild type RSV F protein, both as protein and when expressed from an Ad26 vaccine vector. Here we address the question if there are qualitative differences between the two vaccine platforms for induction of protective immunity. In naïve mice, both Ad26.RSV.preF and preF protein induced humoral responses, whereas cellular responses were only elicited by Ad26.RSV.preF. In RSV pre-exposed mice, a single dose of either vaccine induced cellular responses and strong humoral responses. Ad26-induced RSV-specific cellular immune responses were detected systemically and locally in the lungs. Both vaccines showed protective efficacy in the cotton rat model, but Ad26.RSV.preF conferred protection at lower virus neutralizing titers in comparison to RSV preF protein. Factors that may contribute to the protective capacity of Ad26.RSV.preF elicited immunity are the induced IgG2a antibodies that are able to engage Fcγ receptors mediating Antibody Dependent Cellular Cytotoxicity (ADCC), and the induction of systemic and lung resident RSV specific CD8 + T cells. These data demonstrate qualitative improvement of immune responses elicited by an adenoviral vector based vaccine encoding the RSV preF antigen compared to the subunit vaccine in small animal models which may inform RSV vaccine development. 相似文献
33.
Muhammad I. Zafar Jiequn Han Xu-Hui Zhou & Heng Xiao 《Communications In Computational Physics》2022,32(2):336-363
Partial differential equations (PDEs) play a dominant role in the mathematical modeling of many complex dynamical processes. Solving these PDEs often requires
prohibitively high computational costs, especially when multiple evaluations must be
made for different parameters or conditions. After training, neural operators can provide PDEs solutions significantly faster than traditional PDE solvers. In this work,
invariance properties and computational complexity of two neural operators are examined for transport PDE of a scalar quantity. Neural operator based on graph kernel network (GKN) operates on graph-structured data to incorporate nonlocal dependencies.
Here we propose a modified formulation of GKN to achieve frame invariance. Vector
cloud neural network (VCNN) is an alternate neural operator with embedded frame
invariance which operates on point cloud data. GKN-based neural operator demonstrates slightly better predictive performance compared to VCNN. However, GKN requires an excessively high computational cost that increases quadratically with the
increasing number of discretized objects as compared to a linear increase for VCNN. 相似文献
34.
35.
《JACC: Cardiovascular Interventions》2022,15(7):741-750
ObjectivesThe aim of this study was to report 1-year clinical outcomes following commercial transcatheter left atrial appendage occlusion (LAAO) in the United States.BackgroundThe National Cardiovascular Data Registry LAAO Registry was initiated to meet a condition of Medicare coverage and allow the assessment of clinical outcomes. The 1-year rates of thromboembolic events after transcatheter LAAO in such a large cohort of “real-world” patients have not been previously reported.MethodsPatients entered into the National Cardiovascular Data Registry LAAO Registry for a Watchman procedure between January 1, 2016, and December 31, 2018, were included. The primary endpoint was ischemic stroke. Key secondary endpoints included the rate of ischemic stroke or systemic embolism, mortality, and major bleeding. Major bleeding was defined as any bleeding requiring hospitalization, and/or causing a decrease in hemoglobin level > 2g/dL, and/or requiring blood transfusion that was not hemorrhagic stroke. The Kaplan-Meier method was used for 1-year estimates of cumulative event rates.ResultsThe study population consisted of 36,681 patients. The mean age was 76.0 ± 8.1 years, the mean CHA2DS2-VASc score was 4.8 ± 1.5, and the mean HAS-BLED score was 3.0 ± 1.1. Prior stroke was present in 25.5%, clinically relevant bleeding in 69.5%, and intracranial bleeding in 11.9%. Median follow-up was 374 days (IQR: 212-425 days). The Kaplan-Meier–estimated 1-year rate of ischemic stroke was 1.53% (95% CI: 1.39%-1.69%), the rate of ischemic stroke or systemic embolism was 2.19% (95% CI: 2.01%-2.38%), and the rate of mortality was 8.52% (95% CI: 8.19%-8.87%). The 1-year estimated rate of major bleeding was 6.93% (95% CI: 6.65%-7.21%). Most bleeding events occurred between discharge and 45 days following the procedure.ConclusionsThis study characterizes important outcomes in a national cohort of patients undergoing transcatheter LAAO in the United States. Clinicians and patients can integrate these data in shared decision making when considering this therapy. 相似文献
36.
《Injury》2023,54(2):318-328
PurposeThis study intended to determine the properties of induced membranes after various periods of polymethyl methacrylate (PMMA) retention and the effect of different retention intervals on subsequent defect repair.MethodsModel of a critical bone defect in rabbits was prepared to obtain the induced membrane. For varying intervals of spacer insertion (2, 4, 6, 8, 12, 16, and 20 weeks postoperatively), angiogenesis, osteogenesis, and MSC-related properties were analyzed by immunohistochemistry and western-blot. Furthermore, 2, 4, 6, and 8 weeks after PMMA insertion, bone grafting was performed. Characteristics of defect repair were analyzed by X-ray and micro-CT analysis.ResultsThe induced membrane displayed angiogenesis, osteogenesis, and MSC-related properties from the 2- to 20-week intervals. Quantitation of protein expression (RUNX2, ALP, VEGF, TGF-beta, OCT4, and STRO1) revealed that selected proteins gradually rose to a high level at 4–8 weeks postoperatively and then decreased to a low level over a long time period. Following bone grafting, the most new bone formation was in the group when grafting was performed at 4 weeks, followed by the groups at 2 and 6 weeks, with the least in the group at 8 weeks.ConclusionThe induced membrane displays angiogenesis, osteogenesis, and MSC-related properties from the 2- to 20-week intervals. These were increased to a peak level at 4–8 weeks postoperatively and then gradually decreased. The optimal timing for bone grafting at the second stage in the presented model was 4 weeks after PMMA insertion. 相似文献
37.
随着生活方式的改变,心脑血管疾病逐渐成为全人类死亡的“头号杀手”高于恶性肿瘤、糖尿病等。血脂的升高尤其是低密度脂蛋白胆固醇( LDL-C)的升高与动脉粥样硬化性心血管疾病( ASCVD)的发,生、发展息息相关。现有的专家共识、南提出他汀类药物是降低 LDL-C的一线用药,但仍可能会发生复发性缺血事件。人前蛋白转化酶枯草溶菌素 9(PCSK9)抑制指剂作为一类新型降脂药,有显著降低血 LDL-C水平,同时又可降低脂蛋白( a)的水平,又与 ASCVD与静脉血栓栓塞疾病( VTE)的发病可能相关。本文将系统地阐述新型降脂药 PCSK9抑制剂与 ASCVD、VTE的关系研究进展。 相似文献
38.
39.